P151 Tiotropium Respimat® add-on therapy reduces exacerbation risk in patients with moderate or severe symptomatic asthma, independent of TH2 status: Abstract P151 Table 1
Casale, T, Dahl, R, Virchow, JC, Engel, M, Moroni-Zentgraf, P, Lühmann, R, Kerstjens, HAMVolume:
70
Language:
english
Journal:
Thorax
DOI:
10.1136/thoraxjnl-2015-207770.288
Date:
December, 2015
File:
PDF, 84 KB
english, 2015